During the past decade, Regional Hospital - Omsk conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 1 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Regional Hospital - Omsk" #1 collaborator was "Incyte Corporation" with 2 trials as a collaborator, "Enrollme.ru, LLC" with 1 trials as a collaborator and "Foundation for Cancer Research Support (RakFond)" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Regional Hospital - Omsk" are "Systemic Lupus Erythematosus" (3 trials), "Coronavirus Infection and Hematologic Diseases" (1 trials) and "Lupus Nephritis" (1 trials). Many other conditions were trialed in "Regional Hospital - Omsk" in a lesser frequency.

Most popular intervention types in "Regional Hospital - Omsk" are "Drug" (3 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Baricitinib" (2 trials), "KZR-616" (1 trials), "Non-interventional study" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Regional Hospital - Omsk" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Regional Hospital - Omsk". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Regional Hospital - Omsk, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Regional Hospital - Omsk, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".